| Entry |
|
|---|
| Name |
Acetylcholine-CHRM-GNAQ/11 signaling pathway
|
|---|
| Definition |
Acetylcholine -> CHRM -> (GNAQ,GNA11) -> PLCB |
|---|
| Expanded |
C01996 -> (1128,1131,1133) -> (2776,2767) -> (23236,5330,5331,5332) |
|---|
| Class |
nt06544 Neuroactive ligand signaling
|
|---|
| Type |
Reference
|
|---|
| Pathway |
|
|---|
| Gene |
| 1128 | CHRM1; cholinergic receptor muscarinic 1 |
| 1131 | CHRM3; cholinergic receptor muscarinic 3 |
| 1133 | CHRM5; cholinergic receptor muscarinic 5 |
| 2776 | GNAQ; G protein subunit alpha q |
| 2767 | GNA11; G protein subunit alpha 11 |
| 23236 | PLCB1; phospholipase C beta 1 |
| 5330 | PLCB2; phospholipase C beta 2 |
| 5331 | PLCB3; phospholipase C beta 3 |
| 5332 | PLCB4; phospholipase C beta 4 |
|
|---|
| Metabolite |
|
|---|
| Reference |
|
|---|
| Authors |
Nimgampalle M, Chakravarthy H, Sharma S, Shree S, Bhat AR, Pradeepkiran JA, Devanathan V |
|---|
| Title |
Neurotransmitter systems in the etiology of major neurological disorders: Emerging insights and therapeutic implications. |
|---|
| Journal |
|
|---|
| Reference |
|
|---|
| Authors |
Wang Y, Tan B, Wang Y, Chen Z |
|---|
| Title |
Cholinergic Signaling, Neural Excitability, and Epilepsy. |
|---|
| Journal |
|
|---|
| Reference |
|
|---|
| Authors |
Oleksak P, Novotny M, Patocka J, Nepovimova E, Hort J, Pavlik J, Klimova B, Valis M, Kuca K |
|---|
| Title |
Neuropharmacology of Cevimeline and Muscarinic Drugs-Focus on Cognition and Neurodegeneration. |
|---|
| Journal |
|
|---|
| LinkDB |
|
|---|
